Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among medicaid enrollees with type 2 diabetes

Population Health Management

Volumn 15, Issue 4, 2012, Pages 220-229

  Ou, Huang Tz ^a   Mukherjee, Bhramar ^b   Erickson, Steven R ^c   Piette, John D ^d   Bagozzi, Richard P ^c,e   Balkrishnan, Rajesh ^c  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b Department of Clinical Pharmacy   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACTAOPLUSMET; AVPLUSAMET; GLIBENCLAMIDE PLUS METFORMIN; GLIPIZIDE PLUS METFORMIN; METFORMIN; METFORMIN PLUS PIOGLITAZONE; METFORMIN PLUS ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC DISEASE SCORE; COMORBIDITY; DISEASE SEVERITY; ELIXHAUSER INDEX; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH-RELATED QUALITY OF LIFE COMORBIDITY INDEX; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAID; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PLUS PIOGLITAZONE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLUS PIOGLITAZONE PLUS ROSIGLITAZONE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREDICTIVE VALUE; QUALITY OF LIFE; SCORING SYSTEM;

ADULT; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH BEHAVIOR; HEALTH EXPENDITURES; HEALTH STATUS; HUMANS; MALE; MEDICAID; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; UNITED STATES;

EID: 84865236839     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2011.0037     Document Type: Article

References (55)

1. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
2. Byles JE, D'Este C, Parkinson L, O'Connell R, Treloar C. Single index of multimorbidity did not predict multiple outcomes. J Clin Epidemiol. 2005;58:997-1005.
3. Holman CD, Preen DB, Baynham NJ, Finn JC, Semmens JB. A multipurpose comorbidity scoring system performed better than the Charlson index. J Clin Epidemiol. 2005;58: 1006-1014.
4. Miskulin DC, Martin AA, Brown R, et al. Predicting 1 year mortality in an outpatient haemodialysis population: A comparison of comorbidity instruments. Nephrol Dial Transplant. 2004;19:413-420.
5. Soares M, Salluh JI, Ferreira CG, Luiz RR, Spector N, Rocco JR. Impact of two different comorbidity measures on the 6-month mortality of critically ill cancer patients. Intensive CareMed. 2005;31:408-415.
6. Yan Y, Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Comorbidity indices to predict mortality from Medicare data: Results from the national registry of atrial fibrillation. Med Care. 2005;43:1073-1077.
7. Schneeweiss S, Wang PS, Avorn J, Maclure M, Levin R, Glynn RJ. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med. 2004;19:444-450.
8. Wang PS, Walker A, Tsuang M, Orav EJ, Levin R, Avorn J. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. J Clin Epidemiol. 2000; 53:571-578.
9. Martins M, Blais R. Evaluation of comorbidity indices for inpatient mortality prediction models. J Clin Epidemiol. 2006; 59:665-669.
10. Rius C, Perez G, Martinez JM, et al. An adaptation of Charlson comorbidity index predicted subsequent mortality in a health survey. J Clin Epidemiol. 2004;57:403-408.
11. Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care. 2005;43:607-615.
12. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum. 2005;53:666-672.
13. Wahls TL, Barnett MJ, Rosenthal GE. Predicting resource utilization in a Veterans Health Administration primary Carepopulation: Comparison of methods based on diagnoses and medications. Med Care. 2004;42:123-128.
14. Farley JF, Harley CR, Devine JW. A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care. 2006;12:110-119.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Bevelopment and validation. J Chronic Dis. 1987;40:373-383.
16. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
17. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-203.
18. Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.
19. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care. 2004;42:355-360.
20. Stukenborg GJ, Wagner DP, Connors AF Jr. Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations. Med Care. 2001;39:727-739.
21. Farley D. FDA's Rx for better medication information. FDA Consum. 1995;29:5-10.
22. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29:891-898.
23. Mukherjee B, Ou HT, Wang F, Erickson SR. A new comorbidity index: The health-related quality of life comorbidity index. J Clin Epidemiol. 2011;64:309-319.
24. Adelmann PK. Mental and substance use disorders among Medicaid recipients: Prevalence estimates from two national surveys. Adm Policy Ment Health. 2003;31:111-129.
25. Smith V, Gifford K, Ellis E, Wiles A. Low Medicaid Spending Growth Amid Rebounding State Revenues: Results from a 50-State Budget Survey. State Fiscal Years 2006-2007. Washington, DC: Kaiser Commission on Medicaid and the Uninsured; October 2006.
26. Cohen M. Kaiser Commission on Medicaid and the Uninsured: An Overview of Medicaid Enrollees with Diabetes in 2003. Washington, DC: Kaiser Family Foundation; October 2007.
27. Adamson DM, Chang S, Hansen LG. Health Research Data for the Real World: The MarketScan Databases. Ann Arbor, MI: Thomson Healthcare; 2008.
28. Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res. 1974;9:208-220.
29. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Biffering perspectives. J Clin Epidemiol. 1993;46:1075-1079; discussion 1081-1090.
30. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
31. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47:626-633.
32. Fishman PA, Goodman MJ, Hornbrook MC, Meenan RT, Bachman DJ, O'Keeffe Rosetti MC. Risk adjustment using automated ambulatory pharmacy data: The RxRisk model. Med Care. 2003;41:84-99.
33. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care. 1995;33:783-795.
34. American Diabetes Association. Standards of medical Carein diabetes-2008. Diabetes Care. 2008;31 suppl 1:S12-S54.
35. National Committe for Quality Assirance. HEDIS 2007 Volume 2: Technical Update. Washington, DC: National Committee for Quality Assurance; 2006.
36. North Carolina Division of Medical Assistance. Quality, evaluation, and health outcomes (QEHO) initiatives. Available at: http://www.ncdhhs.gov/dma/ quality/qehoinitiatives. html. Accessed September 27, 2009.
37. Halanych JH, Safford MM, Keys WC, et al. Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care. 2007;30:2999-3004.
38. Clark RE, Weir S, Ouellette RA, Zhang J, Baxter JD. Beyond health plans: Behavioral health disorders and quality of diabetes and asthma Carefor Medicaid beneficiaries. Med Care. 2009;47:545-552.
39. Millett C, Bottle A, Ng A, et al. Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions. J R Soc Med. 2009; 102:369-377.
40. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116.
41. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006; 15:565-574, discussion 575-577.
42. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-457.
43. Cheong C, Barner JC, Lawson KA, Johnsrud MT. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Clin Ther. 2008;30:1893-1907.
44. Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ. 2001;20:461-494.
45. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, eds. 2nd International Symposium on Information Theory. Budapest, Hungary: Akademiai Kiado; 1973:267-281.
46. Burnham KP, Anderson DR. Model Selection and Multi-Model Inference: A Practical Information-Theoretic Approach. 2nd ed. New York: Springer-Verlag; 2002.
47. Anderson DR, Burnham KP. General strategies for the analysis of ringing data. Bird Study. 1999;46:261-270.
48. Kilbourne AM, Reynolds CF 3rd, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13:202-210.
49. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154-2160.
50. Nau DP, Chao J, Aikens JE. The relationship of guidelineconcordant depression treatment and patient adherence to oral diabetes medications. Res Social Adm Pharm. 2005;1: 378-388.
51. Kerr EA, Heisler M, Krein SL, et al. Beyond comorbidity counts: How do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med. 2007;22:1635-1640.
52. Gilmer T, Kronick R, Fishman P, Ganiats TG. The Medicaid Rx model: Pharmacy-based risk adjustment for public programs. Med Care. 2001;39:1188-1202.
53. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854-864.
54. Perkins AJ, Kroenke K, Unutzer J, et al. Common comorbidity scales were similar in their ability to predict health Carecosts and mortality. J Clin Epidemiol. 2004;57: 1040-1048.
55. Baser O, Palmer L, Stephenson J. The estimation power of alternative comorbidity indices. Value Health. 2008;11:946-955.